<![CDATA[76, GSK giver den gas for tiden :o)]]>76, GSK giver den gas for tiden 🐵

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
This study is currently recruiting participants.
Verified February 2012 by University Health Network, Toronto

]]>https://dev.proinvestor.com/forum/topic/448405/76-gsk-giver-den-gas-for-tiden-oRSS for NodeSat, 20 Jun 2026 01:03:13 GMTTue, 14 Feb 2012 14:47:31 GMT60